Livia Tepshi

Title: Livia Tepshi: Innovator in Protective Compounds

Introduction

Livia Tepshi is a notable inventor based in Antony, France. She has made significant contributions to the field of chemistry, particularly in developing compounds that exhibit protective activity against various intracellular threats. Her work is crucial in advancing medical and biochemical research.

Latest Patents

Livia Tepshi holds a patent for "Dihydroquinazolinones exhibiting protective activity against intracellular-acting toxins, intracellular viruses and bacteria." This invention relates to a new family of compounds known as 2,3-dihydroquinazolin-4(1H)-one. These compounds serve as inhibitors of the toxic effects of intracellular-acting toxins, such as ricin, Shiga toxins, and cholera toxin. They also target viruses and bacteria that utilize retrograde transport mechanisms to infect cells, specifically those entering through endocytosis or intracellular parasites.

Career Highlights

Livia Tepshi is associated with the Commissariat à l'Énergie Atomique et aux Énergies Alternatives, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in her field, contributing to advancements in protective medical compounds.

Collaborations

Livia has collaborated with esteemed colleagues, including Audrey Couhert and Jean-Christophe Cintrat. These partnerships have enhanced her research and broadened the impact of her inventions.

Conclusion

Livia Tepshi's contributions to the field of protective compounds are invaluable. Her innovative spirit and dedication to research continue to pave the way for advancements in medical science.